Phase I Using Velcade & Idarubicin in Elderly and Relapsed AML

NCT00382954 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

55

Enrollment

OTHER

Sponsor class

Conditions

Acute Myelogenous Leukemia

Interventions

DRUG: Velcade
DRUG: Idarubicin

Sponsor

University of Kentucky

Collaborators

[object Object]